Ranjan Suri

953 total citations
36 papers, 741 citations indexed

About

Ranjan Suri is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Ranjan Suri has authored 36 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Physiology. Recurrent topics in Ranjan Suri's work include Cystic Fibrosis Research Advances (23 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Ranjan Suri is often cited by papers focused on Cystic Fibrosis Research Advances (23 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Ranjan Suri collaborates with scholars based in United Kingdom, Singapore and India. Ranjan Suri's co-authors include Andrew Bush, Chris Metcalfe, Colin Wallis, Sally J. Dawson, Tony Sirimanna, Simon G. Thompson, Charles Normand, Richard Grieve, Janis K. Shute and Lindsay J. Marshall and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ranjan Suri

35 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranjan Suri United Kingdom 17 532 127 63 57 55 36 741
Ahmet Eyibilen Türkiye 11 138 0.3× 124 1.0× 54 0.9× 11 0.2× 65 1.2× 41 451
Rosana Câmara Agondi Brazil 14 430 0.8× 486 3.8× 15 0.2× 10 0.2× 35 0.6× 55 749
Ana Jotić Serbia 13 92 0.2× 132 1.0× 20 0.3× 16 0.3× 25 0.5× 46 387
Kalliopi Tanou Greece 14 425 0.8× 446 3.5× 9 0.1× 8 0.1× 65 1.2× 17 772
Mark Vandewalker United States 12 1.1k 2.1× 1.4k 10.8× 71 1.1× 97 1.7× 60 1.1× 41 1.7k
V. GRAFF‐LONNEVIG Sweden 18 260 0.5× 700 5.5× 17 0.3× 49 0.9× 37 0.7× 33 1.1k
T.J. Warke United Kingdom 10 438 0.8× 358 2.8× 14 0.2× 9 0.2× 51 0.9× 13 620
Roy Patterson United States 13 228 0.4× 247 1.9× 14 0.2× 14 0.2× 15 0.3× 24 702
I. Chanal France 18 339 0.6× 1.1k 8.5× 172 2.7× 9 0.2× 33 0.6× 29 1.6k
Laura Tenero Italy 13 150 0.3× 176 1.4× 8 0.1× 20 0.4× 64 1.2× 44 421

Countries citing papers authored by Ranjan Suri

Since Specialization
Citations

This map shows the geographic impact of Ranjan Suri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjan Suri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjan Suri more than expected).

Fields of papers citing papers by Ranjan Suri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranjan Suri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjan Suri. The network helps show where Ranjan Suri may publish in the future.

Co-authorship network of co-authors of Ranjan Suri

This figure shows the co-authorship network connecting the top 25 collaborators of Ranjan Suri. A scholar is included among the top collaborators of Ranjan Suri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranjan Suri. Ranjan Suri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Gwyneth, L. Thia, Janet Stocks, et al.. (2020). Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year. Journal of Cystic Fibrosis. 19(6). 896–901. 16 indexed citations
2.
Dawson, Sally J., et al.. (2014). High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis. Journal of Cystic Fibrosis. 14(2). 248–254. 56 indexed citations
3.
Suri, Ranjan, et al.. (2014). Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?. International Journal of Pediatric Otorhinolaryngology. 78(6). 969–973. 14 indexed citations
4.
Bossley, Cara & Ranjan Suri. (2013). An update on paediatric severe asthma : review article. 26(3). 114–120. 1 indexed citations
5.
Williams, Johanna, Catherine Wilson, Lorenzo Biassoni, Ranjan Suri, & MS Fewtrell. (2012). Dual energy x-ray absorptiometry and quantitative ultrasound are not interchangeable in diagnosing abnormal bones. Archives of Disease in Childhood. 97(9). 822–824. 22 indexed citations
6.
7.
Williams, Jane, Jonathan C. K. Wells, Christian Benden, et al.. (2010). Body composition assessed by the 4-component model and association with lung function in 6–12-y-old children with cystic fibrosis. American Journal of Clinical Nutrition. 92(6). 1332–1343. 22 indexed citations
8.
Suri, Ranjan, Emmanouil Paraskakis, & Andrew Bush. (2007). Alveolar, but not bronchial nitric oxide production is elevated in cystic fibrosis. Pediatric Pulmonology. 42(12). 1215–1221. 25 indexed citations
9.
Suri, Ranjan, Chris Metcalfe, Colin Wallis, & Andrew Bush. (2006). Assessing the usefulness of outcomes measured in a cystic fibrosis treatment trial. Respiratory Medicine. 101(2). 254–260. 31 indexed citations
10.
Suri, Ranjan. (2005). The Use of Human Deoxyribonuclease (rhDNase) in the Management of Cystic Fibrosis. BioDrugs. 19(3). 135–144. 57 indexed citations
11.
Suri, Ranjan, Chris Metcalfe, Colin Wallis, & Andrew Bush. (2004). Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis. Pediatric Pulmonology. 37(4). 305–310. 26 indexed citations
12.
Marshall, Lindsay J., et al.. (2003). Free Secretory Component from Cystic Fibrosis Sputa Displays the Cystic Fibrosis Glycosylation Phenotype. American Journal of Respiratory and Critical Care Medicine. 169(3). 399–406. 15 indexed citations
13.
Grieve, Richard, Simon G. Thompson, Charles Normand, et al.. (2003). A COST-EFFECTIVENESS ANALYSIS OF rhDNase IN CHILDREN WITH CYSTIC FIBROSIS. International Journal of Technology Assessment in Health Care. 19(1). 71–79. 21 indexed citations
14.
Suri, Ranjan, Lindsay J. Marshall, Colin Wallis, et al.. (2003). Safety and use of sputum induction in children with cystic fibrosis. Pediatric Pulmonology. 35(4). 309–313. 47 indexed citations
15.
Suri, Ranjan, Lindsay J. Marshall, Colin Wallis, et al.. (2002). Effects of Recombinant Human DNase and Hypertonic Saline on Airway Inflammation in Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 166(3). 352–355. 55 indexed citations
16.
17.
Suri, Ranjan, et al.. (2001). Effects of rhDNase and hypertonic saline on airway inflammation in children with cystic fibrosis. UCL Discovery (University College London). 4 indexed citations
18.
Suri, Ranjan, Chris Metcalfe, Belinda Lees, et al.. (2001). Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. The Lancet. 358(9290). 1316–1321. 120 indexed citations
19.
Aw, Tar Choon, et al.. (2000). Differential Diagnosis of Hb EE and Hb E-β°-Thalassemia by Protein and DNA Analyses. Acta Haematologica. 103(2). 84–89. 7 indexed citations
20.
Suri, Ranjan, et al.. (1996). Effect of diazepam sedation on arterial oxygen saturation during esophagogastroduodenoscopy: a placebo-controlled study.. PubMed. 15(2). 40–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmet Eyibilen Breakdown of academic impact, for papers by Rosana Câmara Agondi Breakdown of academic impact, for papers by Ana Jotić Breakdown of academic impact, for papers by Kalliopi Tanou Breakdown of academic impact, for papers by Mark Vandewalker Breakdown of academic impact, for papers by V. GRAFF‐LONNEVIG Breakdown of academic impact, for papers by T.J. Warke Breakdown of academic impact, for papers by Roy Patterson Breakdown of academic impact, for papers by I. Chanal Breakdown of academic impact, for papers by Laura Tenero
Rankless by CCL
2026